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Introduction: Cerebral venous sinus thrombosis is a rare condition. The most frequent symptoms and signs are
headache, focal seizures with or without secondary generalization, unilateral or bilateral paresis and papilledema.
We report a case of transverse sinus and superior sagittal sinus thrombosis that presented with diplopia in a
pregnant woman.
Case presentation: A 34-year-old Malay woman, gravida 3 para 2 at 8 weeks of pregnancy, was admitted for
hyperemesis gravidarum, presented with sudden onset of diplopia, blurring of vision and headache. A magnetic
resonance scan of her brain showed the presence of cerebral edema with no space occupying lesion, but magnetic
resonance venography ultimately revealed right transverse sinus and superior sagittal sinus thrombosis. The patient
was treated with anticoagulation for 1 year, after which the patient recovered fully.
Conclusion: Due to its diverse and varied neurological presentation, cerebral venous sinus thrombosis should be
considered in almost any brain syndrome.
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Cerebral venous sinus thrombosis is a rare condition
and its clinical presentation is extremely variable and
life-threatening [1,2]. The most frequent symptoms and
signs are headache (95%), focal seizures with or without
secondary generalization (47%), unilateral or bilateral
paresis (43%) and papilledema (41%) [3]. Patients who
are at risk of developing venous thrombus formation are
those with hypercoagulable states, dehydration, adjacent
infectious processes, low cerebral blood flow, oral con-
traceptives, hormone replacement therapy, pregnancy,
and puerperium [1,2,4].Case presentation
A 34-year-old Malay woman, gravida 3 para 2 at 8 weeks
of pregnancy, presented with nausea and vomiting for 4
days’ duration. She was admitted into our prenatal ward
and was diagnosed as hyperemesis gravidarum. After 3
days in the ward, she developed sudden onset of diplopia* Correspondence: zunaina@kb.usm.my
2Department of Ophthalmology, School of Medical Sciences, Universiti Sains
Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
Full list of author information is available at the end of the article
© 2012 Munira et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orassociated with blurring of vision in both eyes and
fronto-temporal headache.
It was not associated with fever or rash. There was no
history of facial or sinus infection and no history of re-
cent head trauma. She was completely well previously
with no significant medical history. She had never
experienced similar symptoms during her previous preg-
nancy and there was no family history of similar condi-
tions noted.
She was alert and conscious and her vital signs were
stable. The visual acuity in her right eye was 6/24 and
improved to 6/6 with pinhole. Her left eye visual acuity
was 6/24 and improved to 6/9 with pinhole. Extraocular
muscle examination showed bilateral sixth cranial nerve
palsy. Anterior segment examination was normal. Fun-
dus examination showed bilateral papilledema. Other
cranial nerves were normal. There were no peripheral
neurological signs noted.
A magnetic resonance scan of the patient’s brain
showed presence of cerebral edema with normal orbits
and no space occupying lesion (Figure 1). Magnetic res-
onance venography (MRV) revealed right transverse
sinus and superior sagittal sinus thrombosis (Figure 2).
Her coagulation profile and blood investigations forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Magnetic resonance scan of the orbit and brain showed cerebral edema with normal orbits and no space occupying lesion.
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gram was also normal.
Our Neurology Team diagnosed cerebral venous sinus
thrombosis. The patient was treated with intravenous
heparin for 1 week followed by subcutaneous heparin for
3 weeks. Diplopia and headache had gradually resolved
and her visual acuity had improved after 1 month of
anticoagulation. MRV was repeated at 1 month after the
initiation of treatment and showed resolved cerebral ven-
ous sinus thrombosis (Figure 3). Because cerebral venous
sinus thrombosis poses a high risk of thromboembolism
in this patient and furthermore no other safer drug was
available, warfarin was subsequently initiated. Warfarin
was started at 13 weeks’ period of amenorrhea and she
was treated with long-term warfarin for 11 months. The
dose of warfarin was adjusted carefully based on her
International Normalised Ratio (INR) reading with the
aim to maintain her INR between 2 and 3. The patient
had given birth uneventfully at term. The baby was born
at 38 weeks period of amenorrhea via spontaneous vagi-
nal delivery with birth weight of 2.8kg, without any com-
plication and there was no identifiable syndrome noted.Discussion
Cerebral venous sinus thrombosis is a rare and poten-
tially deadly condition. It occurs 10 to 13 times more
often during the puerperium than during pregnancy and
is also very rare during the first trimester. The most
common postulated mechanism on how cerebral venous
sinus thrombosis can affect a pregnant woman is hyper-
coagulable state brought about by the pregnancy itself
and further aggravated by dehydration and anemia [1].
Once the thrombus is formed, it may enlarge and
cause venous congestion. This will lead to cerebral
edema with mass effect and a resultant increase of intra-
cranial pressure. If the thrombus is left untreated, the
intracranial pressure will continue to rise and the vascu-
lar supply is compromised. Finally ischemia will ensue.
According to The International Study on Cerebral
Vein and Dural Sinus Thrombosis, the most commonly
affected site is the transverse sinus, followed by superior
sagittal sinus and straight sinus [5]. Other less common
sites are the cortical vein, jugular vein and internal cere-
bral vein. In most patients, thrombosis occurs in more
than one sinus.
Figure 2 Magnetic resonance venography showing absence of signal of part of right transverse sinus and superior sagittal sinus.
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from sudden to progressive over weeks, so it can mimic
other conditions such as tumor, stroke, or benign intra-
cranial hypertension. Headache, focal deficits, seizures,
disorders of consciousness, and papilledema, which can
present in isolation or in association, are the most fre-
quent signs [6,7]. Diplopia is not a common presenting
symptom of cerebral venous sinus thrombosis [8]. If the
intracranial pressure is quite high, a sixth cranial nerve
palsy may develop. Usually it presents as a false localiz-
ing sign, but it may also indicate extension of thrombus
into the inferior petrosal sinus [9].
According to the guidelines of the European Feder-
ation of Neurological Societies, the first line treatment
for cerebral venous and dural sinus thrombosis is antith-
rombolysis. The rationale for its use is to favor spontan-
eous thrombus resolution and to recanalize the occluded
vein or sinus, to avoid thrombus propagation, to treat
underlying prothrombotic condition and to prevent
complications such as pulmonary thromboembolism.
Treatment is usually started with dose-adjusted intraven-
ous heparin between 3000 and 5000 international units
or body-weight-adjusted subcutaneous low-molecular-
weight heparin, until the patient stabilizes. Treatment
for this acute phase is followed by oral anticoagulationwith warfarin to prevent recurrence and thrombosis in
other parts of the body.
The optimal duration of oral treatment varies, but the
accepted practice is 3 months for idiopathic cases, be-
tween 3 and 6 months for cases related to pregnancy or
oral contraceptive use, and between 6 and 12 months in
patients with hereditary thrombophilia [6,10]. This treat-
ment is aimed for INR of 2 or 3. Some articles suggest
catheter-guided local thrombolysis in patients who de-
teriorate despite adequate anticoagulation.
The prognosis is quite good in 80% of patients with
obstetric causes [1] and has a mortality rate of between
5 and 10% [1,5,11]. Our patient was treated with antic-
oagulation for 1 year, after which the patient had recov-
ered fully and had given birth uneventfully at term.Conclusions
Due to its diverse and varied neurological presentation,
cerebral venous sinus thrombosis should be considered
in almost any brain syndrome.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
Figure 3 Repeat magnetic resonance venography at 1 month after anticoagulation showed visualized flow signal of right transverse
and superior sagittal sinus.
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